If reports prove accurate, tomorrow may mark the most significant shift in federal drug policy in 55 years. Multiple administration sources are signaling that President Trump is poised to follow through on what has long been teased: rescheduling cannabis from Schedule I to Schedule III under the Controlled Substances Act.
Trending
- Medical Marijuana Helps Cancer Patients With Pain, Anxiety And Nausea, Government Study Shows
- Trump-Linked PAC Uses Marijuana Business Donations To Campaign For GOP Lawmakers Who Voted Against Legalization
- Pennsylvania Medical Cannabis Program Audit Calls for Increased Oversight
- San Francisco Officials Propose Rules For Cannabis Cafes Where People Could Consume While Listening To Live Music And Ordering Food
- Report: Cannabis Excise Taxes Totaled Over $3.5 Billion Across 30 U.S. States Last Year
- Bill Directing Federal Health Officials To Track Testing For Marijuana And Other Drugs In Hospital ERs Set For House Vote This Week
- FDA Officials Lay Out Plan To Make Psychedelic Therapies Available To Patients ‘More Quickly’
- Ohio Marijuana Dispensary Closes Amid Reports Of ‘Adverse Health Effects’ In People Who Bought Vapes
